Advertisement

Topics

Cell type switch helps colon cancer evade treatment, study suggests

20:00 EDT 15 May 2018 | AAAS

(Rockefeller University Press) Researchers in Germany have discovered that colon cancers are often resistant to existing drug treatments because they are composed of two different cell types that can replace each other when one cell type is killed. The study, which will be published May 16 in the Journal of Experimental Medicine, suggests that combination therapies targeting both cell types at once may be more effective at treating colorectal cancer, the third highest cause of cancer-related death in the United States.

Original Article: Cell type switch helps colon cancer evade treatment, study suggests

NEXT ARTICLE

More From BioPortfolio on "Cell type switch helps colon cancer evade treatment, study suggests"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...